Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs– Volume 1: Cinnamon Global Markets, Competitors And Opportunities- 2014-2019 Analysis And Forecast, New Report Launched

Diabetes is a metabolic disorder arising mainly due to the fault in the production of insulin or mounting resistance to its action. In the case of Diabetes, the most serious problem is the side effect, which occurs due to the accumulation of glucose. This excess glucose is converted into various compounds and also into free radicals, which damage the vital organs and organelles. Diabetes was seriously underrated as a threat to global public health until very recently. Today, Diabetes now ranks as one of the greatest public health challenges in the history of mankind. There were 382 million people with Diabetes, or 8.3% of the global population, in 2013. By 2035, this number will be 10.1%, equal almost 600 million people worldwide.

Diabetes has a very large economic impact. For example, in the US the cost of diagnosed Diabetes in 2012 is estimated at US$245 billion, including $176 billion in direct medical costs. In 2013, the average Diabetes related expenditures per person in the US was USD9,800. Globally, per capita Diabetes related expenditures in 2013 was USD1,436. Further, the global market for Diabetes medications is estimated at approximately USD45 billion in 2013 and is growing 10.5% annually overall, with insulin sales increasing at a 14.2% CAGR.

The currently available antidiabetic drugs manage the blood glucose levels under normal range by supplementing insulin, improving insulin sensitivity, increasing insulin secretion from the pancreas, decreasing glucose absorption from the intestinal tract and/or glucose uptake by tissue cells.

Today, the management of Diabetes without any side effect is still a challenge to the medical fraternity. However, a wide array of plant-derived active principles has demonstrated antidiabetic activity. These natural medicines modulate blood sugar levels through a variety of mechanisms. In some cases their effects are similar to conventional medicines.

This report looks at the use of medicinal plants, rather than pharmaceutical drugs, to both prevent and treat Diabetes. Specifically, it looks in detail at one of these plants: Cinnamon. Cinnamon is widely used and available and the market for it is well developed. The modern literature indicates that the potential antidiabetic properties of Cinnamon have been studied for over 20 years. Numerous trials have been conducted in humans to determine the metabolic effects of Cinnamon.

Global production of Cinnamon is forecast to rise 15% annually in value, and 6% annually in volume, between 2014 and 2019. The report provides the following additional information:

A detailed look at the Diabetes market including its incidence by country now and during the next 20 years, economic impacts and costs by type, especially medications.

Analysis of medicinal plants to manage Diabetes including experimental studies on the hypoglycaemic activity and bioactive components of 66 plants.

The potential of Cinnamon for the management of Diabetes including its biological effects, molecular mechanisms of action and clinical studies.

Analysis of the global market for Cinnamon including production, imports, exports and traders.

Spanning over 328 pages “Diabetes: Herbal Bioactive Molecules Vs. Pharmaceutical Drugs– Volume 1: Cinnamon Global Markets, Competitors And Opportunities- 2014-2019 Analysis And Forecast” report Covering the Executive Summary, Introduction, Diabetes Market Overview, Medicinal Plants and Diabetes, Cinnamon and Diabetes, Cinnamon Market Overview, Company Profiles, Appendix 1: Diabetes Overview, Appendix 2: Insulin Overview.

Know more about this report at – http://mrr.cm/Ztk

Find all Pharmaceutical Manufacturing Reports at: 

http://www.marketresearchreports.com/pharmaceutical-manufacturing